EP3334721
CGRP viðtakamótverkendur
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
5.8.2016EP published:
28.4.2021EP application number:
16751123.7
EP translation filed:
5.7.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
4.8.2036Expiry date:
4.8.2023
Title:
CGRP RECEPTOR ANTAGONISTS
Timeline
Today
5.8.2016EP application
28.4.2021EP Publication
5.7.2021Translation submitted
15.10.2021Registration published
4.8.2023Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
COATES, David AndrewAddress:
Indianapolis, IN 46206-6288, US
Name:
FORTNER, Kevin CharlesAddress:
Indianapolis, IN 46206-6288, US
Name:
MASSEY, Steven MarcAddress:
Indianapolis, IN 46206-6288, US
Name:
MYERS, Jason KennethAddress:
Indianapolis, IN 46206-6288, US
Name:
NAVARRO, AntonioAddress:
Indianapolis, IN 46206-6288, US
Name:
SIEGEL, Miles GoodmanAddress:
Indianapolis, IN 46206-6288, US
Name:
STUCKY, Russell DeanAddress:
Indianapolis, IN 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562203996 PDate:
12.8.2015Country:
US
Number:
201562266867 PDate:
14.12.2015Country:
US
Classification
Categories:
C07D 401/12, A61K 31/4439, A61P 25/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.7.2021
Expires: 4.8.2022
Payer: Patice ehf.
Number: 7
Paid: 20.7.2022
Expires: 4.8.2023
Payer: Patice ehf.